BID and neuroblastoma: The functional relevance of tBid in the Bortezomib-conferred sensitization of neuroblastoma cells to TRAIL-induced apoptosis was demonstrated by RNA interference experiments showing that silencing of Bid also significantly reduced apoptosis in cells co-treated with TRAIL and Bortezomib [8].